Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection
- PMID: 9498466
- DOI: 10.1086/517810
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection
Abstract
The distribution of serotypes of group B streptococci (GBS) isolated from 67 infants with early-onset sepsis are described. Case-infants were assembled from 13 hospitals across the United States from 15 July 1995 to 5 February 1997 through prospective active surveillance. The distribution of GBS serotypes was Ia, 40%; Ib, 9%; II, 6%; III, 27%; V, 15%; and nontypeable, 3%. Type V occurred more frequently in the northeast region (New York and New Jersey) than in other regions (29% vs. 9%, P = .06). Conversely, type III occurred significantly less frequently in the northeast region than other regions (10% vs. 35%, P = .04). GBS types Ia, III, and V accounted for 82% of the isolates. This report supports previous observations about the emergence of GBS type V, but our data caution that conclusions about serotype distributions based on one geographic location or on a small number of patients may not be generally applicable. Continued monitoring seems necessary for the design of a GBS vaccine.
Similar articles
-
Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany.Clin Infect Dis. 2005 Mar 1;40(5):760-3. doi: 10.1086/427942. Epub 2005 Feb 2. Clin Infect Dis. 2005. PMID: 15714426
-
Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing.J Clin Microbiol. 2004 Jan;42(1):146-50. doi: 10.1128/JCM.42.1.146-150.2004. J Clin Microbiol. 2004. PMID: 14715745 Free PMC article.
-
Serotypes and clinical manifestations of group B streptococcal infections in western Sweden.Clin Microbiol Infect. 2000 Jan;6(1):9-13. doi: 10.1046/j.1469-0691.2000.00007.x. Clin Microbiol Infect. 2000. PMID: 11168030
-
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.Vaccine. 2013 Aug 28;31 Suppl 4:D52-7. doi: 10.1016/j.vaccine.2013.02.029. Vaccine. 2013. PMID: 23973347 Review.
-
An overview of global GBS epidemiology.Vaccine. 2013 Aug 28;31 Suppl 4:D7-12. doi: 10.1016/j.vaccine.2013.01.009. Vaccine. 2013. PMID: 23973349 Review.
Cited by
-
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.Infect Immun. 2002 Nov;70(11):6409-15. doi: 10.1128/IAI.70.11.6409-6415.2002. Infect Immun. 2002. PMID: 12379721 Free PMC article.
-
Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolates.J Clin Microbiol. 1999 Aug;37(8):2564-7. doi: 10.1128/JCM.37.8.2564-2567.1999. J Clin Microbiol. 1999. PMID: 10405402 Free PMC article.
-
Specific Lipopolysaccharide Serotypes Induce Differential Maternal and Neonatal Inflammatory Responses in a Murine Model of Preterm Labor.Am J Pathol. 2015 Sep;185(9):2390-401. doi: 10.1016/j.ajpath.2015.05.015. Epub 2015 Jul 26. Am J Pathol. 2015. PMID: 26212908 Free PMC article.
-
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.J Clin Microbiol. 2003 Jun;41(6):2659-61. doi: 10.1128/JCM.41.6.2659-2661.2003. J Clin Microbiol. 2003. PMID: 12791897 Free PMC article.
-
Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.J Clin Microbiol. 2008 Apr;46(4):1285-91. doi: 10.1128/JCM.02105-07. Epub 2008 Feb 20. J Clin Microbiol. 2008. PMID: 18287314 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical